NCT07624721

Brief Summary

With this study, the investigators want to find out how well different stages of acute kidney injury (AKI), match with the actual filtering ability of the kidneys in very sick adults in the intensive care unit (ICU). Kidney function will be measured using a urine test that estimates how much waste the kidneys can clear from the blood. The investigators will also compare two ways of diagnosing and staging AKI: one based on how much urine a person makes, and the other based on blood creatinine levels (a waste product that rises when kidney function worsens). In addition, the investigators will examine how factors that can be changed (such as treatments or medications) and factors that cannot be changed (such as age or existing health conditions) may affect this relationship. Finally, the investigators will look at whether drops in kidney function are linked to problems like high potassium levels in the blood and a buildup of acid in the body.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,416

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 19, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 20, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
Last Updated

June 3, 2026

Status Verified

June 1, 2026

Enrollment Period

18 days

First QC Date

April 20, 2026

Last Update Submit

June 1, 2026

Conditions

Keywords

intensive careacute kidney injury

Outcome Measures

Primary Outcomes (1)

  • The association between KDIGO AKI stage and measured creatinine clearance.

    During each patient's entire ICU stay, the KDIGO stage will be determined at every time point for which a measured creatinine clearance value is available. As this is a retrospective analysis, the timing and frequency of measured creatinine clearance assessments will vary between patients throughout their ICU stay. Measured creatine clearance will be corrected for body surface area and expressed as mL/min/1.73 m². The KDIGO classification categorizes AKI severity from mild to severe using a scoring system ranging from stage 1 to stage 3.

    from ICU admission until ICU discharge (average 4 days)

Secondary Outcomes (5)

  • The association between KDIGO AKI 'urine output criteria' and 'serum creatinine criteria' and the measured creatinine clearance.

    from ICU admission until ICU discharge (average 4 days)

  • The association of gender with differences in measured creatinine clearance according to AKI severity.

    from ICU admission until ICU discharge (average 4 days)

  • Comparison of measured creatinine clearance in patients with chronic kidney disease (CKD) in the different AKI (KDIGO) stages

    from ICU admission until ICU discharge (average 4 days)

  • Association of measured creatinine clearance and KDIGO stage with complications

    from ICU admission until ICU discharge (average 4 days)

  • The association between measured creatinine clearance and estimated glomerular filtration rate (eGFR)

    from ICU admission until ICU discharge (average 4 days)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients admitted on the ICU of Ghent Univesity Hospital between 1 December 2024 and 30 November 2025

You may qualify if:

  • Admission ICU of Ghent university hospital
  • Availability of at least one serum creatinine clearance

You may not qualify if:

  • chronic RRT before ICU admission
  • RRT during ICU
  • Missing or incomplete data preventing KDIGO AKI classification

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent university hospital

Ghent, 9000, Belgium

Location

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2026

First Posted

June 3, 2026

Study Start

April 1, 2026

Primary Completion

April 19, 2026

Study Completion

April 19, 2026

Last Updated

June 3, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Data of individuals will not be shared according to General Data Protection Regulation (GDPR)

Locations